Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON
  1. Accueil Zonebourse
  2. Actions
  3. France
  4. Euronext Paris
  5. Ipsen
  6. Actualités
  7. Autres langues
    IPN   FR0010259150

IPSEN

(IPN)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur IPSEN
21/10GLOBAL MARKETS LIVE : Tesla, Unilever, Paypal, Elliott, Novartis...
21/10IPSEN : Lifts FY21 Sales Growth Guidance to At Least 11%
21/10IPSEN : Strong results in Q3 as we Focus. Together. For patients �...
21/10Ipsen S.A. Revises Sales Guidance for the Year 2021
21/10Ipsen S.A. Reports Unaudited Sales Results for the Third Quarter and Nine Months Ended ..
19/10OPINIONES DE LOS ANALISTAS DEL DÍA : Endesa, IAG, Umicore, Prosus, Aston Martin, EasyJet, ..
19/10Lluvia de resultados
18/10IPSEN : Signs $446 Million Deal With Accent Therapeutics To Develop Blood, Bone Marrow Can..
18/10IPSEN : Accent collaboration – 18 October 2021
18/10Ipsen Adds Another Program Into Its Pre-Clinical R&D Oncology Pipeline Through an Exclu..
12/10REUTERS EVENTS PHARMA 2021 : Transforming Medical Affairs to ...
11/10Ipsen Appoints Mari Scheiffele as EVP and President, Specialty Care International, Effe..
01/10IPSEN : Rethinking risk factors this Liver Cancer Awareness Month
29/09IPSEN : Q3 Results – Conference Call – October 21, 2021
20/09IPSEN : ESMO 2021, Cabometyx demonstrates sustained 78% reduction in risk of disease progr..
20/09MIRATI THERAPEUTICS : taps industry veteran Meek as CEO
20/09IPSEN : Thyroid Cancer Drug Shows Sustained Effect In Late-Stage Study
18/09Cabometyx® Demonstrates Sustained 78% Reduction in Risk of Disease Progression or Death..
17/09LAZARD : Reportedly Picked for Strategic Review of French Drugmaker Ipsen's Consumer Healt..
16/08IPSEN : announces withdrawal of palovarotene NDA, confirming intention to re-submit follow..
13/08Acciones europeas registran su mejor racha ganadora desde 2006 y cierran cuarta semana ..
13/08European stocks log best winning streak since 2006, fourth week of gains
13/08BOLSA : Europa cierra al alza pese a aumento de infecciones por variante Delta
13/08Dax steigt auf 16.000 Punkte - Kursfeuerwerk bei Zooplus
13/08EUROSTOXX 50 : Borse Europa si avviano a chiudere quarta settimana consecutiva in rialzo
13/08BOLSA : Europa sube al ignorar inversores los temores al coronavirus
13/08European stocks log best winning streak since 2006, fourth week of gains
13/08EN DIRECTO DESDE LOS MERCADOS : Zooplus, Adidas, Boeing, Walt Disney, Airbnb, DoorDash...
13/08EUROSTOXX 50 : Las bolsas europeas se encaminan a una cuarta semana de ganancias
13/08BOLSA DE MADRID : Sin miedo a nada
13/08IPSEN : Drops US FDA Application for Ultra-Rare Genetic Disorder Drug
13/08Ipsen Announces Withdrawal of Palovarotene NDA, Confirming Intention to Re-Submit Follo..
02/08Top Midday Gainers
02/08EXICURE : Working With Ipsen to Develop Potential Therapeutics for Neurodegenerative Disor..
02/08IPSEN : Exicure to Develop Treatment for Neurodegenerative Illnesses
02/08Addex ernennt Mikhail Kalinichev zum Leiter Translational Science
02/08IPSEN : Exicure collaboration-2 August 2021
02/08PRESS RELEASE : Addex Appoints Seasoned Pharma Drug Researcher Mikhail Kalinichev as Head ..
02/08Ipsen and Exicure Enters into Exclusive Collaboration Targeting Rare Neurodegenerative ..
30/07IPSEN : Exceeding again our CSR-based targets
29/07IPSEN : delivers strong H1 2021 results and upgrades full-year...
29/07Ipsen S.A. Raises Sales Guidance for the Fiscal Year 2021
28/07GLOBAL MARKETS LIVE : Apple, Alphabet, Facebook, Pfizer, McDonald's...
28/07IPSEN : strengthens its pre-clinical Oncology pipeline with an exclusive worldwide-collabo..
28/07IPSEN : BAKX Therapeutics to Develop Cancer Treatment
27/07IPSEN : BAKX collaboration-27 July 2021
27/07Ipsen and BAKX Therapeutics Inc. Signs Exclusive Worldwide-Collaboration Agreement to R..
16/07GLOBAL MARKETS LIVE : Intel, Moderna, Burberry, Pfizer, SoftwareOne, Swisscom...
16/07IPSEN : and IRLAB enter exclusive worldwide licensing agreement aimed to improve the lives..
16/07EN DIRECTO DESDE LOS MERCADOS : Rio Tinto, Pfizer, Intel, Moderna, Burberry, Ericsson, Pum..
16/07IPSEN : Irlab Enter License Deal on Potential Parkinson's Disease Treatment
15/07IPSEN : IRLAB_15 July 2021.pdf
15/07IRLAB THERAPEUTICS : Ipsen and IRLAB enter exclusive worldwide licensing agreement aimed t..
15/07IPSEN : H1 Results – Conference Call – July 29, 2021
28/06GLOBAL MARKETS LIVE : Volkswagen, Daimler, Tesla, Burberry, UBS...
28/06IPSEN : Exelixis_COSMIC-312 TLR – 28 June 2021.pdf
18/06IPSEN : A year-long partnership with the ISPC
17/06IPSEN : launches Perspectives Matter around World Kidney Cance...
14/06ISPRM 2021 : New Ipsen analysis highlights potential treatment gap in adults living with s..
11/06IPSEN : Finds Potential Treatment Gap Among Spasticity Patients in US
11/06IPSEN : ISPMR 2021 – 11 June 2021.pdf
07/06IPSEN : Exelixis Say Phase 3 Trial of Cabozantinib Drug in Differentiated Thyroid Cancer M..
07/06IPSEN : Exelixis COSMIC-311 ASCO – 7 June 2021.pdf
07/06Exelixis and Ipsen Announce Detailed Results from Phase 3 COSMIC-311 Pivotal Trial of C..
05/06IPSEN : World Environment Day 2021
02/06La fiesta aún no ha terminado
02/06EN DIRECTO DESDE LOS MERCADOS : Stellantis, Amazon, U-Blox, Cloudera, Tesla, Credit Suisse..
31/05TODAY'S ANALYST RECOMMENDATIONS : Advanced Micro Devices, AstraZeneca, Bodycote, Medtronic..
31/05La bolsa recibió cuatro de cinco
31/05OPINIONES DE LOS ANALISTAS DEL DÍA : Endesa, Kering, Ipsen, Valneva, Ahold Delhaize, Bekae..
31/05EN DIRECTO DESDE LOS MERCADOS : Nike, Accor, Renault, Lindt, Ipsen, Intel, Nestlé, Volkswa..
31/05IPSEN : US FDA Accepts Ipsen's Approval Request For Ultra-Rare Genetic Disorder Drug
28/05IPSEN : Palovarotene FDA acceptance – 28 May 2021.pdf
28/05IPSEN : Compensation policy for corporate officers, result of vote SM – 28 mai 2021...
28/05IPSEN : Information relating to compensation elements of ALC – 28 mai 2021.pdf
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur IPSEN